Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04731857 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT04731857 · ClinicalTrials.gov record · last posted 2026-05-04

Diagnostic Value of Exome/ Genome Sequencing, Conventional Methods in Rare Diseases and Familial Tumor Syndromes

Name: Diagnostic Value of Exome/ Genome Sequencing, Conventional Methods in Rare Diseases and Familial Tumor Syndromes — clinical trial record (NCT04731857)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: EXGEFATU

StatusRecruiting

PhaseNot specified

SponsorUniversity Hospital Tuebingen

Started2021-02-18

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

For the retrospective data analysis, patients with genetic diseases of any age and, if available, other family members, for whom genetic analyzes were carried out between 10/2016 and 12/2020, should be included. This equates to approximately 13,000 records, minus combined analyzes in the same patient, an estimated 12,000 individuals.

Amendment record 5 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 5 times since 2021-01-26; most recent amendment 2026-04-28. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2021-02-24

Status change Not Yet Recruiting→Recruitingv1

Trial Details

NCT Number	NCT04731857
Lead Sponsor	University Hospital Tuebingen
Conditions	Rare Diseases, Genetic Predisposition
Enrollment	12,000 participants
Start Date	2021-02-18
Primary Completion	2030-02 (estimated)
Study Completion	2031-02 (estimated)
Updated on ClinicalTrials.gov	2026-05-04